PT Penta Valent Tbk (ISX:PEVE) Research & Development: Rp Mil (TTM As of . 20)


ISX:PEVE PT Penta Valent Tbk ISX:PEVE
15 GF Score
Price Rp318.00
! 1 Warning Sign
View Full Analysis

What is PT Penta Valent Tbk Research & Development?

PT Penta Valent Tbk ISX:PEVE +3.25% 15 Research & Development is Rp Mil as of . 20. GuruFocus rates ISX:PEVE with a GF Score™ of 15/100. The stock has 1 warning sign investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. PT Penta Valent Tbk's Research & Development for the six months ended in . 20 was Rp0.00 Mil. PT Penta Valent Tbk does not have enough years/quarters to calculate the Research & Development for the trailing twelve months (TTM) ended in . 20.

PT Penta Valent Tbk  (ISX:PEVE) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

PT Penta Valent Tbk Research & Development Related Terms

PT Penta Valent Tbk Research & Development Historical Data

* Premium members only.

The historical data trend for PT Penta Valent Tbk's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Penta Valent Tbk Research & Development Chart

PT Penta Valent Tbk Annual Data
Trend
Research & Development

PT Penta Valent Tbk Semi-Annual Data
Research & Development
ISX:PEVE
15GF Score
PT Penta Valent Tbk ISX:PEVE
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PT Penta Valent Tbk Research & Development Calculation

This is the expense the company spent on research and development.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of Rp Mil mean?
PT Penta Valent Tbk (ISX:PEVE) has a Research & Development of Rp Mil as of . 20. Research and development expense is the total cost for research and development activities. View historical data on PT Penta Valent Tbk and its competitors.
Is PT Penta Valent Tbk's Research & Development too high?
PT Penta Valent Tbk's current Research & Development is Rp Mil. Overall, PT Penta Valent Tbk has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does PT Penta Valent Tbk's Research & Development compare to competitors?
PT Penta Valent Tbk's Research & Development of Rp Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on PT Penta Valent Tbk and its competitors. PT Penta Valent Tbk's current Research & Development is Rp Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Penta Valent Tbk stock overvalued right now?
PT Penta Valent Tbk (ISX:PEVE) has a current Research & Development of Rp Mil. The current Research & Development is Rp Mil. PT Penta Valent Tbk's overall GF Score™ is 15/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For PT Penta Valent Tbk (ISX:PEVE), the current Research & Development is Rp Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PT Penta Valent Tbk Business Description

Address Jalan Kedoya Raya No. 33, Kedoya Utara, Kebon Jeruk, West Jakarta, Jakarta, IDN, 11520
PT Penta Valent Tbk is engaged in the distribution of pharmaceutical products, medical equipment, and consumer products. The company divides its business into two segments that contribute to the company's operating revenues, namely Pharmaceutical Products and Consumer Products. It generates the majority of the revenue from the Pharmaceutical Products segment. Pharmaceutical Segment a special segment for distributing pharmaceutical products or medicines and medical devices. Geographically, the company operates in Java and Outside Java, of which derives maximum revenue from Java.
15GF Score

Get the complete analysis for ISX:PEVE

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp318.00
Price